Myers, R. et al. (2018). Ultrasound-mediated cavitation does not decrease the activity of small molecule, antibody or viral-based medicines. Int J Nanomedicine. Jan 10;13:337-349. PMID: 9391793

Sanders, T. et al. (2020). Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying. Pharmaceutics. Apr 24;12(4). pii: E388. PMID: 32344667

Adkin, CF. et al. (2012). Multiple exon skipping strategies to by-pass dystrophin mutations. Neuromuscul Disord. Apr;22(4):297-305. PMID: 22182525

Aung-Htut, M. et al. (2020). Splice modulating antisense oligonucleotides restore some acidalpha-glucosidase activity in cells derived from patients with lateonset Pompe disease. Sci Rep. Apr 21;10(1):6702. PMID: 32317649.

Greer, K. et al. (2015). Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient. Mol Genet Genomic Med. 3(4):320-6. PMID: 26247048

Greer, KL. et al. (2014). Targeted exon skipping to correct exon duplications in the dystrophin gene. Mol Ther Nucleic Acids. Mar 18;3:e155. PMID: 24643206

Fletcher, S. et al. (2013). Antisense suppression of donor splice site mutations in the dystrophin gene transcript. Mol Genet Genomic Med. Sep;1(3):162-73. PMID: 24498612

Fletcher, S. et al. (2012). Targeted exon skipping to address “leaky” mutations in the dystrophin gene. Mol Ther Nucleic Acids. Oct 16;1:e48. PMID: 23344648

Toh, ZY. et al. (2016). Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies. PLoS One. Jan 8;11(1):e0145620. PMID: 26745801

Zaric, M. et al. (2017). Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays. J Control Release. Dec 28;268:166-175. PMID: 29056444

Bachy, V. et al. (2013). Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci U S A. Feb 19;110(8):3041-6. PMID: 23386724

Becker, PD. et al. (2015). Skin vaccination with live virus vectored microneedle arrays induce long lived CD8(+) T cell memory. Vaccine. Sep 8;33(37):4691-8. PMID: 25917679

O’Brien, LM. et al. (2014). Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse. Virology. Mar;452-453:324-33. PMID: 24461913

Zaric, M. et al. (2019) Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8+ effector recruitment to mucosal tissues.  Nat. Comms.  10:2214 

Dyer, A. et al. (2016). Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. Mol Ther Oncolytics. Dec 10;4:18-30. PMID: 28345021

Thoma, C. et al. (2013). Adenovirus serotype 11 causes less long-term intraperitoneal inflammation than serotype 5: implications for ovarian cancer therapy. Virology. Dec;447(1-2):74-83. PMID: 24210101

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

Pathirana, J. et al. (2021). Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy. Vaccine. 2021 Aug 9;39(34):4793-4799. PMID: 34275675.

Dowling, D.J. et al. (2022) “Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to dtap vaccination,” Scientific Reports, 12(1)

Troost-Kind, B. et al. (2021). Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression. PMID: 34762680.

Islamuddin, M. et al. (2021). Inhibition of Chikungunya Virus Infection by 4-Hydroxy-1-Methyl-3-(3-morpholinopropanoyl)quinoline-2(1H)-one (QVIR) Targeting nsP2 and E2 Proteins. ACS.

Liu, JL. et al. (2020). Stabilization of a Broadly Neutralizing Anti-Chikungunya Virus Single Domain Antibody. Front Med (Lausanne). Jan 28;8:626028. PMID: 33585527

Liu, JL. et al. (2018). Selection of Single-Domain Antibodies Towards Western Equine Encephalitis Virus. Antibodies.

Merbah, M. et al. (2020). A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins. J Immunol Methods. 2020 Oct 3;112874. PMID: 33022219.

Seiler, BT. (2019). Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment. F1000 Research. PMID: 31275563.

Ushijima, Y. et al. (2021). Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis. 2021 Mar 17;21(1):265. PMID: 33731022.

Ganganboina, AB. et al. (2021). Cargo encapsulated hepatitis E virus-like particles for anti-HEV antibody detection. Biosens Bioelectron. 2021 Aug 1;185:113261. PMID: 33962156

Nasrin, F. et al. (2021). Design and Analysis of a Single System of Impedimetric Biosensors for the Detection of Mosquito-Borne Viruses. Biosensors (Basel). 2021 Oct 7;11(10):376. PMID: 34677332

Ganganboina, AK. et al. (2021). Cargo encapsulated Hepatitis E virus-like particles for anti-HEV antibody detection. Biosensors and Bioelectronics. 2021 Apr.

Gaurav, N. et al. (2021). Role of nuclear localization signals in the DNA delivery function of Chikungunya virus capsid protein. Arch Biochem Biophys. 2021 Mar 15;702:108822. PMID: 33722536.

Islamuddin, M. et al. (2021). Inhibition of Chikungunya Virus Infection by 4-Hydroxy-1-Methyl-3-(3-morpholinopropanoyl)quinoline-2(1H)-one (QVIR) Targeting nsP2 and E2 Proteins. ACS Omega.

Pedraza-Escalona, M. et al. (2020). Isolation and characterization of high anity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. Research Square (preprint).

Tuekprakhon, A. (2018). Broad-Spectrum Monoclonal Antibodies Against Chikungunya Virus Structural Proteins: Promising Candidates For Antibody-Based Rapid Diagnostic Test Development. PLOS One. PMID: 30557365

Lin, H.-C. et al. (2023) “Development of a novel chikungunya virus-like replicon particle for rapid quantification and screening of neutralizing antibodies and antivirals,” Microbiology Spectrum.

Anwar, S. et al. (2020). Development and verification of an enzyme-linked immunosorbent assay for the quantification of toxoid A and toxoid B from Clostridioides difficile. J Immunol Methods. 2021 Jan;488:112917. PMID: 33221460

Huang, JH. et al. (2015). Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A. PLoS One. Aug 13;10(8):e0135045. PMID: 26271033

Matchett, WE. et al. (2020). A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile. Vaccines. Aug 22;8(3):470. PMID: 32842679

Tian, JH. et al. (2017). Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Vaccine. Jul 24;35(33):4079-4087. PMID: 28669616

Andreano, E. et al. (2020). Extremely potent human monoclonal antibodies from convalescent Covid-19 patients. bioRxiv (preprint).

Andriuta, D. et al. (2020). COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.  Journal of Neurology. 2020 Jun 11 : 1–2. PMID: 32529577.

Brochot, E. et al. (2020). Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers. medRxiv (preprint).

Casswell, S. et al. (2021). COVID-19 Antibody Testing of Patients Admitted to the ICU by a Novel, Point-of-Care Assay, and the Relationship to Survival. Research Square (preprint).

Doremalen, NV. et al. (2020). ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques. bioRxiv (preprint).

Emanuele, A. et al. (2020). Identification of neutralizing human monoclonal antibodies from Italian Covid-19 convalescent patients. bioRxiv (preprint).

Fritz. et al. (2020). High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health (preprint).

Garrett, ME. et al. (2021). High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies. Cell. May 27;184(11):2927-2938.e11. PMID: 34010620

Jagtap, S. et al. (2021). Evaluation of Spike Protein Antigens for SARS-CoV-2 Serology. medRxiv (preprint).

Kay, GA. et al. (2021). Immunoglobulin-G enzyme-linked immunosorbent assay predicts neutralising antibody response in convalescent SARS-CoV-2 patients. Research Square (preprint).

Kei, H. et al. (2021). Nasal delivery of single-domain antibodies improves symptoms of SARS-CoV-2 infection in an animal model. bioRxiv (preprint).

Lassauniere, R. et al. (2021). Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2. NPJ Vaccines. 2021 Dec 20;6(1):156. PMID: 34930909

Lee, Y-K. et al. (2022). Carbohydrate Ligands for COVID-19 Spike Proteins. Viruses.

Mast, FD. et al. (2021). Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2. bioRxiv (preprint). PMID: 33851164.

Mazhari, R. et al. (2021). SARS-CoV-2 Multi-Antigen Serology Assay. Methods Protoc, 4(4), 72. MDPI.

Moore, AC. et al. (2020). Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection. bioRxiv (preprint).

Piccoli, L. et al. (2020). Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020 Sep 16. PMCID: PMC7494283.

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

Shaw, AM. et al. (2020). Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 July 07: 5638-5646.

Tan, Q. et al. (2022) “High sensitivity detection of SARS-COV-2 by an optofluidic hollow eccentric core fiber,” Biomedical Optics Express, 13(9), p. 4592. 

Biering, SB. et al. (2021). SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling. bioRxiv (preprint). PMID: 34931188

McClements, J. et al. (2022) “Molecularly imprinted polymer nanoparticles enable rapid, reliable, and robust point-of-care thermal detection of SARS-COV-2,” ACS Sensors, 7(4), pp. 1122–1131.

Miller, LM. et al. (2021). Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry. J Am Chem Soc. 2021 Mar 17;143(10):3959-3966. PMID: 33657316.

Imbrechts, M. et al. (2021). Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model. medRxiv (preprint).

Solastie, A. et al. (2021). A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Microbiol Spectr. 2021 Nov 17;9(3):e0113121. PMID: 34787485

Wechselberger, C. et al. (2020). Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients. Journal of Clinical Virology. 2020 Aug 11;131. PMID: 32810840.

Wellens, J. et al. (2021). Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease. medRxiv (preprint).

Windsor, W.J. et al. (2022) “Harmonization of multiple SARS-COV-2 reference materials using the who is (NIBSC 20/136): Results and implications,” Frontiers in Microbiology, 13.

Aguilar Rangel, M. et al. (2022) “Fragment-based computational design of antibodies targeting structured epitopes,” Science Advances, 8(45).

Brochot, E. et al. (2020). Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers. medRxiv (preprint).

Fritz, M. et al. (2022) “First evidence of natural SARS-COV-2 infection in domestic rabbits,” Veterinary Sciences, 9(2), p. 49.

Haghighi, M. et al. (2021). Different formulations of inactivated SARS-CoV-2 vaccine candidates in human compatible adjuvants: Potency studies in mice showed different platforms of immune responses. Research Square (preprint).

Heaney, CD. et al. (2021). Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. medRxiv (preprint). 2021 Feb 1;2021.01.28.21250717. PMID: 33532806.

Hansen, F. et al. (2022) “SARS-COV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract,” Cell Reports, 38(11), p. 110515.

Imbrechts, M. et al. (2021). Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model. medRxiv (preprint).

Lehman, AA. et al. (2020). Deconvoluting the T cell response to SARS-CoV-2: specificity versus chance- and cognate cross-reactivity. bioRxiv (preprint).

Lenguiya, L.H. et al. (2023) “Whole-genome characterization of SARS-COV-2 reveals simultaneous circulation of three variants and a putative recombination (20B/20H) in pets, Brazzaville, republic of the Congo,” Viruses, 15(4), p. 933. 

Puig, H. et al. (2021). Simultaneous detection of SARS-CoV-2 RNA and host antibodies enabled by a multiplexed electrochemical sensor platform. medRxiv (preprint).

Ravlo, E. et al. (2022) “Antiviral immunoglobulins of chicken egg yolk for potential prevention of SARS-COV-2 infection,” Viruses, 14(10), p. 2121.

Reynolds, C.J. et al. (2022) “Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-COV-2 exposure,” Science, 377(6603).

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

Rosenke, K. et al. (2021). UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates. Emerg Microbes Infect. 2021 Nov 1;1-38. PMID: 34724885.

Rosadas, C. et al. (2022) “Detection and quantification of antibody to SARS COV 2 receptor binding domain provides enhanced sensitivity, specificity and utility,” Journal of Virological Methods, 302, p. 114475.

Solastie, A. et al. (2021). A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Microbiol Spectr. 2021 Nov 17;9(3):e0113121. PMID: 34787485

Thomaz, D.V. et al. (2022) “Effect of recombinant antibodies and MIP nanoparticles on the electrical behavior of impedimetric biorecognition surfaces for SARS-COV-2 spike glycoprotein: A short report,” Electrochem, 3(3), pp. 538–548.

Andriuta, D. et al. (2020). COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF.  Journal of Neurology. 2020 Jun 11 : 1–2. PMID: 32529577.

Bewley, KR. et al. (2021). Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques. Sci Adv. 2021 Sep 10;7(37):eabg7996. PMID: 34516768

Bixler, SL. et al. (2021). Aerosol Exposure of Cynomolgus Macaques to SARS-CoV-2 Results in More Severe Pathology than Existing Models. bioRxiv (preprint).

Bixler, S.L. et al. (2022) “Exposure route influences disease severity in the COVID-19 cynomolgus macaque model,” Viruses, 14(5), p. 1013.

Brochot, E. et al. (2020). Anti-Spike, anti-Nucleocapsid and neutralizing antibodies in SARS-CoV-2 hospitalized patients and asymptomatic carriers. medRxiv (preprint).

Everett, HE. et al. (2021). Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection. Viruses. 2021 Jan 15;13(1):E113. PMID: 33467732.

Faustini, SE. et al. (2021). Development of a high sensitivity ELISA detecting IgG, A & M antibodies to the SARS‐CoV‐2 spike glycoprotein in serum and saliva. Immunology. PMID: 33932228.

Fotis, C. et al. (2020). Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays. medRxiv (preprint).

Fritz. et al. (2020). High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health (preprint).

Golden, JW. (2021). Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. J Gen Virol. 102(5). PMID: 33961540.

Heaney, CD. et al. (2021). Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. medRxiv (preprint). 2021 Feb 1;2021.01.28.21250717. PMID: 33532806.

Hill, H.J. et al. (2022) “Comparison of a prototype SARS-COV-2 lateral flow immunoassay with the BINAXNOWTM COVID-19 antigen card,” Viruses, 14(12), p. 2609.

Ijaz, S. et al. (2022) “Mapping of SARS-COV-2 IGM and IGG in gingival crevicular fluid: Antibody dynamics and linkage to severity of COVID-19 in hospital inpatients,” Journal of Infection, 85(2), pp. 152–160.

Johnston, SC. et al. (2021). Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure. PLoS One. 2021 Feb 2;16(2):e0246366. PMID: 33529233.

Kay, GA. et al. (2021). Immunoglobulin-G enzyme-linked immunosorbent assay predicts neutralising antibody response in convalescent SARS-CoV-2 patients. Research Square (preprint).

Leon, G. et al. (2020). Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. bioRxiv (preprint).

Maltz-Matyschsyk, M. et al. (2023) “Development of a biomarker signature using grating-coupled fluorescence plasmonic microarray for diagnosis of MIS-C,” Frontiers in Bioengineering and Biotechnology, 11.

Piccoli, L. et al. (2020). Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020 Sep 16. PMCID: PMC7494283.

Pisanic, N. et al. (2023) “Methodological approaches to optimize multiplex oral fluid SARS-COV-2 IGG assay performance and correlation with serologic and neutralizing antibody responses,” Journal of Immunological Methods, 514, p. 113440.

Randad, PR. et al. (2021). Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection. medRxiv (preprint).

Salguero, FJ. et al. (2020). Comparison of Rhesus and Cynomolgus macaques as an authentic model for COVID-19. bioRxiv (preprint).

Shaw, AM. et al. (2020). Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 July 07: 5638-5646.

Solastie, A. et al. (2021). A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies. Microbiol Spectr. 2021 Nov 17;9(3):e0113121. PMID: 34787485

Timilsina, S.S. et al. (2023) “Rapid quantitation of SARS-COV-2 antibodies in clinical samples with an electrochemical sensor,” Biosensors and Bioelectronics, 223, p. 115037.

Tsai, W-Y. et al. (2021). A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter. Emerg Microbes Infect. 2021 Apr 30;1-38. PMID: 33929934

Uprichard, S.L. et al. (2022) “Antibody response to SARS-COV-2 infection and vaccination in covid-19-naïve and experienced individuals,” Viruses, 14(2), p. 370.

Emig, CJ. et al. (2021). AUG-3387, a Human-Derived Monoclonal Antibody Neutralizes SARS-CoV-2 Variants and Reduces Viral Load from Therapeutic Treatment of Hamsters In Vivo. bioRxiv (preprint).

Leon, G. et al. (2020). Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19. bioRxiv (preprint).

Wellens, J. et al. (2021). Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease. medRxiv (preprint).

Haga, K. et al. (2021). Nasal delivery of single-domain antibodies improves symptoms of SARS-CoV-2 infection in an animal model. BioRxiv (preprint).

Mazhari, R. et al. (2021). SARS-CoV-2 Multi-Antigen Serology Assay. Methods Protoc, 4(4), 72. MDPI.

Shaw, AM. et al. (2020). Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 July 07: 5638-5646.

Shaw, AM. et al. (2020). Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 July 07: 5638-5646.

Francisco, JS. et al. (2021). Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat Commun. 2021 Feb 24;12(1):1260. PMID: 33627662.

Randad, PR. et al. (2020). COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. Journal of Clinical Microbiology. PMID: 32511537

Randad, PR. et al. (2021). Durability of SARS-CoV-2-specific IgG responses in saliva for up to 8 months after infection. medRxiv (preprint).

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

McNaughton, AL. et al. (2021). Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses. MedRxiv (preprint).

Pattinson, D. et al. (2021). A method to reduce ELISA serial dilution assay workload applied to SARS-CoV-2 and seasonal HCoVs. medRxiv (preprint)

Pattinson, D. et al. (2021). A method to reduce ELISA serial dilution assay workload applied to SARS-CoV-2 and seasonal HCoVs. medRxiv (preprint)

Mazhari, R. et al. (2021). SARS-CoV-2 Multi-Antigen Serology Assay. Methods Protoc, 4(4), 72. MDPI.

Rosado, J. et al. (2021). Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study. Lancet Microbe. 2021 Feb;2(2):e60-e69. PMID: 33521709.

Brockbank, SMV. et al, (2021). SARS-CoV-2 comprehensive receptor profiling: mechanistic insight to drive new therapeutic
strategies. bioRxiv (preprint).

Valero, K.  et al. (2021). A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry. Proc Natl Acad Sci USA. 2021 Dec 14;118(50):e2112942118. PMID: 34876524

Ali, A.M. et al. (2022) “Rhamnolipid nano-micelles inhibit SARS-COV-2 infection and have no dermal or eye toxic effects in rabbits,” Antibiotics, 11(11), p. 1556.

Bullen, G. et al. (2021). Cross-Reactive SARS-CoV-2 Neutralizing Antibodies From Deep Mining of Early Patient Responses.  Front Immunol. 2021; 12: 678570. PMID: 34211469

Davies, SP. et al. (2021). The hyperlipidaemic drug fenofibrate significantly reduces infection by SARS-CoV-2 in cell culture models. bioRxiv (preprint).

Dicken, SJ. et al. (2021). Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2. bioRxiv (preprint).

Dub, T. et al. (2020). Transmission of SARS-CoV-2 following exposure in school settings: experience from two Helsinki area exposure incidents. medRxiV (preprint).

Ferrari, M. et al. (2021). Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variants. bioRxiv (preprint).

Jagtap, S. et al. (2021). Evaluation of Spike Protein Antigens for SARS-CoV-2 Serology. medRxiv (preprint).

Kumar, V.  et al. (2021). Multicentric Evaluation of a Novel Point of Care Electrochemical ELISA Platform for SARS-CoV-2 Specific IgG and IgM Antibody Assay. MedRxiv (preprint).

Mazzini, L. et al. (2021). Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples. J Immunol Methods . 2021 Feb;489:112937. PMID: 33253698.

Moakes, RJA. et al. (2020). Formulation of a composite nasal spray enabling enhanced surface coverage and prophylaxis of SARS-COV-2. bioRxiv (preprint).

Sil, BK. et al. (2021). Development and performance evaluation of a rapid in-house ELISA for retrospective serosurveillance of SARS-CoV-2. PLoS One. 2021 Feb 2;16(2):e0246346. PMID: 33529223.

Southworth, T., Jackson, N. and Singh, D. (2022) “Airway immune responses to COVID-19 vaccination in COPD patients and healthy subjects,” European Respiratory Journal, 60(2), p. 2200497.

Tan, Q. et al. (2022) “High sensitivity detection of SARS-COV-2 by an optofluidic hollow eccentric core fiber,” Biomedical Optics Express, 13(9), p. 4592.

Vojdani, A. et al. (2021). Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases. Front. Immunol., 19 January 2021.

Wang, J. et al. (2022). Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection. Cell Rep Methods. 2022 Feb 1;100170. PMID: 35128513

Qi, S. et al. (2023) “Porous cellulose thin films as sustainable and effective antimicrobial surface coatings,” ACS Applied Materials & Interfaces, 15(17), pp. 20638–20648.

Yang, J. et al. (2023) “Development of nucleocapsid-specific monoclonal antibodies for SARS-COV-2 and their ELISA diagnostics on an automatic microfluidic device,” Sensors and Actuators B: Chemical, 380, p. 133331. 

Basile, K. et al. (2022) “Improved neutralisation of the SARS-COV-2 omicron variant following a booster dose of Pfizer-BioNTech (BNT162B2) COVID-19 vaccine,” Viruses, 14(9), p. 2023.

Jung, J.W. et al. (2022) “Plant‐based expression and characterization of SARS‐COV‐2 virus‐like particles presenting a native Spike protein,” Plant Biotechnology Journal, 20(7), pp. 1363–1372.

Lenguiya, L.H. et al. (2023) “Whole-genome characterization of SARS-COV-2 reveals simultaneous circulation of three variants and a putative recombination (20B/20H) in pets, Brazzaville, republic of the Congo,” Viruses, 15(4), p. 933. 

Cerracchio, C. et al. (2022) “Canine coronavirus activates aryl hydrocarbon receptor during in vitro infection,” Viruses, 14(11), p. 2437.

Cerracchio, C. et al. (2022) “Effectiveness of the fungal metabolite 3-O-methylfunicone towards canine coronavirus in a canine fibrosarcoma cell line (A72),” Antibiotics, 11(11), p. 1594. 

Pattinson, D. et al. (2022) “A novel method to reduce ELISA serial dilution assay workload applied to SARS-COV-2 and seasonal HCoVs,” Viruses, 14(3), p. 562. 

Belij-Rammerstorfer, S. et al. (2022) “Development of anti-Crimean-congo hemorrhagic fever virus GC and NP-specific ELISA for detection of antibodies in domestic animal sera,” Frontiers in Veterinary Science, 9. 

Golden, JW. et al. (2019). GP38-Targeting Monoclonal Antibodies Protect Adult Mice Against Lethal Crimean-Congo Hemorrhagic Fever Virus Infection. Science Advances. PMID: 31309159.

Tran, P.-T.-H. et al. (2022) “Enhanced seroconversion to West Nile virus proteins in mice by West Nile Kunjin replicon virus-like particles expressing glycoproteins from Crimean–Congo hemorrhagic fever virus,” Pathogens, 11(2), p. 233.

Belij-Rammerstorfer, S. et al. (2022) “Development of anti-Crimean-congo hemorrhagic fever virus GC and NP-specific ELISA for detection of antibodies in domestic animal sera,” Frontiers in Veterinary Science, 9.

Saunders, J.E. et al. (2023) “Adenoviral vectored vaccination protects against Crimean-Congo haemorrhagic fever disease in a lethal challenge model,” eBioMedicine, 90, p. 104523. 

Dorfman, JR. et al. (2021). In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection: evidence for boosting but not protection. Clin Infect Dis. 2021 Feb 9. PMID: 33560335

John, S. et al. (2018). Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. Vaccine. 2018 Mar 14;36(12):1689-1699. PMID: 29456015

Hassett, KJ. et al. (2021). Impact of lipid nanoparticle size on mRNA vaccine immunogenicity. J Control Release. 2021 May 18;S0168-3659(21)00237-6. PMID: 34019945

Koppert, S. et al. (2021). Affinity tag coating enables reliable detection of antigen-specific B cells in ImmunoSpot assays. medRxiV (preprint).

Liu, Y. et al. (2020). A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection. J Virol. 2019 Nov 13;93(23). pii: e00747-19. PMID: 31511385

Schampera, MS. et al. (2019). Role of Pentamer Complex-Specific and IgG Subclass 3 Antibodies in HCMV Hyperimmunoglobulin and Standard Intravenous IgG Preparations. Med Microbiol Immunol. Feb, 208(1), 69-80. PMID: 30203132

Almehmadi, MM. (2014). CD56+ T-cells in Relation to Cytomegalovirus in Healthy Subjects and Kidney Transplant Patients. University of Liverpool.

Speth, P. et al. (2021). Immunocompromised Patients with Therapy-Refractory Chronic Skin Diseases Show Reactivation of Latent Epstein‒Barr Virus and Cytomegalovirus Infection. J Invest Dermatol. 2021 Sep 1;S0022-202X(21)02161-8. PMID: 34480891

Gogesch, P. et al. (2019). Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus Vaccine. Vaccines (Basel). Sep, 7(3), 104. PMID: 31480520

Abraham, PR. et al. (2021). Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes. Sci Rep. 2021 Dec 8;11(1):23699. PMID: 34880307

Albuquerque, D.C. et al. (2022) “Combined detection of molecular and serological signatures of viral infections: The dual assay concept,” Biosensors and Bioelectronics, 210, p. 114302.

Badolato-Corrêa, J. et al. (2018). Human T cell responses to Dengue and Zika virus infection compared to Dengue/Zika coinfection. Immun Inflamm Dis. Jun;6(2):194-206. PMID: 29282904

Galula, JU. et al. (2021). Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies. Diagnostics (Basel). 2021 Apr 21;11(5):741. PMID: 33919324

Jayathilaka, D. et al. (2018). Role of NS1 Antibodies in the Pathogenesis of Acute Secondary Dengue Infection. Nature Communications. PMID: 30531923

Matsanuga, K-I. et al. (2021). High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification. Nucleic Acids Res. 2021 Jun 25;gkab515. PMID: 34169309

Nunes, PCG. et al. (2018). NS1 Antigenemia and Viraemia Load: Potential Markers of Progression to Dengue Fatal Outcome. Viruses. PMID: 29903980

Poltep, K. et al. (2021). Development of a Dengue Virus Serotype-Specific Non-Structural Protein 1 Capture Immunochromatography Method. Sensors 2021, 21(23), 7809.

Puerta-Guardo, H. et al. (2022) “Flavivirus NS1 triggers tissue-specific disassembly of intercellular junctions leading to barrier dysfunction and vascular leak in a gsk-3β-dependent manner,” Pathogens, 11(6), p. 615.

Silva, MS. et al. (2021). Rational selection of hidden epitopes for a molecularly imprinted electrochemical sensor in the recognition of heat-denatured dengue NS1 protein. Biosensors and Bioelectronics.

Tsai, W-Y. et al. (2018). Use of Urea Wash ELISA to Distinguish Dengue Virus Infections. CDC.

Tsai, W-Y. et al. (2017). Distinguishing Secondary Dengue Virus Infection from Zika Virus Infection with Previous Dengue by a Combination of 3 Simple Serological Tools. Clinical Infectious Diseases. PMID: 29020159 

Versiani, A.F. et al. (2023) “Performance of vidas® diagnostic tests for the automated detection of dengue virus NS1 antigen and of anti-dengue virus IGM and IGG antibodies: A multicentre, international study,” Diagnostics, 13(6), p. 1137.

Warner, N.L., Core, S.B. and Frietze, K.M. (2022) “Unbiased identification of dengue virus non-structural protein 1 peptides for use in vaccine design,” Vaccines, 10(12), p. 2028.

Abraham, PR. et al. (2021). Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes. Sci Rep. 2021 Dec 8;11(1):23699. PMID: 34880307

Biering, SB. et al. (2021). SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling. bioRxiv (preprint). PMID: 34931188

Chen, HR. et al. (2016). Dengue Virus Non-structural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy. PLoS Negl Trop Dis. Jul 13;10(7):e0004828. PMID: 27409803

Chen, HR. et al. (2018). Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability. PLoS Pathog. Apr 27;14(4):e1007033. PMID: 29702687

Cheung, Y. et al. (2020). A Critical Role for Perivascular Cells in Amplifying Viral Haemorrhage Induced by Dengue Virus Non-Structural Protein 1. BioRxiv. Feb 14. (Preprint).

Cheng, Y.-L. et al. (2022) “Antibodies against the SARS-COV-2 S1-RBD cross-react with dengue virus and Hinder Dengue Pathogenesis,” Frontiers in Immunology, 13. 

Conde, JN. et al. (2016). Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins. J Virol. Oct 14;90(21):9570-9581. PMID: 27512066

Galula, JU. et al. (2021). Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies. Diagnostics (Basel). 2021 Apr 21;11(5):741. PMID: 33919324.

Garcia-Oliva, C. et al. (2020). Efficient Synthesis of Muramic and Glucuronic Acid Glycodendrimers as Dengue Virus Antagonists. Chemistry. Feb, 26(7), 1588-1596. PMID: 31644824

Jayathilaka, D. et al. (2018). Role of NS1 Antibodies in the Pathogenesis of Acute Secondary Dengue Infection. Nature Communications. PMID: 30531923

Lee, P. et al. (2020). Relative contribution of non-structural protein 1 in dengue pathogenesis. BioRxiv. Feb 02. (Preprint).

Mani, S. et al. (2018). Serological Cross Reactivity between Zika and Dengue Viruses in Experimentally Infected Monkeys. Virologica Sinica. PMID: 30155852

Matsanuga, K-I. et al. (2021). High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification. Nucleic Acids Res. 2021 Jun 25;gkab515. PMID: 34169309

Puerta-Guardo, H. et al. (2019). Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism. Cell Reports. PMID: 30726741

Roberts, A., Mahari, S. and Gandhi, S. (2022) “Signal enhancing gold nanorods (GNR) and antibody modified electrochemical nanosensor for ultrasensitive detection of Japanese encephalitis virus (JEV) secretory non-structural 1 (NS1) biomarker,” Journal of Electroanalytical Chemistry, 919, p. 116563.

Tam, JO. et al. (2017). A comparison of nanoparticle-antibody conjugation strategies in sandwich immunoassays. J Immunoassay Immunochem. 38(4):355-377. PMID: 27982728

Abraham, PR. et al. (2021). Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes. Sci Rep. 2021 Dec 8;11(1):23699. PMID: 34880307

Galula, JU. et al. (2021). Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies. Diagnostics (Basel). 2021 Apr 21;11(5):741. PMID: 33919324.

Kimoto, M. et al. (2023) “Success probability of high-affinity DNA aptamer generation by genetic alphabet expansion,” Philosophical Transactions of the Royal Society B: Biological Sciences, 378(1871). 

Matsanuga, K-I. et al. (2021). High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification. Nucleic Acids Res. 2021 Jun 25;gkab515. PMID: 34169309

Ushijima, Y. et al. (2021). Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis. 2021 Mar 17;21(1):265. PMID: 33731022.

Abraham, PR. et al. (2021). Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes. Sci Rep. 2021 Dec 8;11(1):23699. PMID: 34880307

Galula, JU. et al. (2021). Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies. Diagnostics (Basel). 2021 Apr 21;11(5):741. PMID: 33919324.

Heringer, M. et al. (2017). Dengue type 4 in Rio de Janeiro, Brazil: case characterization following its introduction in an endemic region. BMC Infect Dis. Jun 9;17(1):410. PMID: 28599640

Matsanuga, K-I. et al. (2021). High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification. Nucleic Acids Res. 2021 Jun 25;gkab515. PMID: 34169309

Ushijima, Y. et al. (2021). Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis. 2021 Mar 17;21(1):265. PMID: 33731022.

Nagar, PK. et al. (2020). Detection of Dengue Virus-Specific IgM and IgG Antibodies through Peptide Sequences of Envelope and NS1 Proteins for Serological Identification. Journal of Immunology Research. 2020 August 4th: 1-8.

Durham, N. et al. (2019). Functional characterization and lineage analysis of broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics. BioRxiv. Oct 02. (Preprint).

Merbah, M. et al. (2020). A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins. J Immunol Methods. 2020 Oct 3;112874. PMID: 33022219.

Rogers, TF. et al. (2017). Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors. Sci Immunol. Aug 18;2(14). PMID: 28821561

Awadalkareem, A. et al. (2018). Multiplexed FluroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells. The Journal of Immunology. PMID: 30413671

Deliot, A. et al. (2017) Visualization of Dengue virus like particles interacting with antibodies. The 16th European Microscopy Congress, Lyon, France.

Goldman, ER. et al. (2017). Bglbrick strategy for the construction of single domain antibody fusions. Heliyon. Dec 28;3(12):e00474. PMID: 29322100

Lecouturier, V. et al. (2018). Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes. Vaccine. Apr 26. pii: S0264-410X(18)30562-0. PMID: 29706291

Metz, SW. et al. (2018). Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope. Virol J. 2018 Apr 2;15(1):60. PMID: 29609659

Monferrer, A. et al. (2022) “Broad-spectrum virus trapping with heparan sulfate-modified DNA origami shells,” ACS Nano, 16(12), pp. 20002–20009.

Nascimento, EJ. et al. (2021). Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus. Int J Mol Sci. 2021 Nov 5;22(21):12004. PMID: 34769432

Ponndorf, D. et al. (2020). Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice. Plant Biotechnology Journal. PMID: 33099859

Sanchez-Vargas, LA. et al. (2019). Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand. Front Immunol. Jun, 10, 1359. PMID: 31263466

Seiler, BT. (2019). Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment. F1000 Research. PMID: 31275563.

Tsuji, I. et al. (2021). Development of a novel assay to assess the avidity of dengue virus-specific antibodies elicited in response to a tetravalent dengue vaccine. J Infect Dis. 2021 Feb 3;jiab064. PMID: 33534885.

Tsuji, I. et al. (2022) “Somatic hypermutation and framework mutations of variable region contribute to Anti-Zika virus-specific monoclonal antibody binding and function,” Journal of Virology, 96(11). 

Folly, A.J. et al. (2022) “Evidence for overwintering and autochthonous transmission of Usutu virus to wild birds following its redetection in the United Kingdom,” Transboundary and Emerging Diseases, 69(6), pp. 3684–3692.

Pedraza-Escalon, M. et al. (2020). Isolation and characterization of high anity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. Research Square (preprint).

Ponndorf, D. et al. (2020). Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice. Plant Biotechnology Journal. PMID: 33099859

Tuekprakhon, A. et al. (2018). Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development. PLoS One. PMID: 30557365

Warner, NL. et al. (2021). Development of Bacteriophage Virus-Like Particle Vaccines Displaying Conserved Epitopes of Dengue Virus Non-Structural Protein 1. Vaccines 2021, 9(7), 726.

Wilken, L. et al. (2023) “Recombinant modified vaccinia virus ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice,” Vaccines, 11(4), p. 714. 

Tantirimudalige, S.N. et al. (2022) “The ganglioside GM1A functions as a coreceptor/attachment factor for dengue virus during infection,” Journal of Biological Chemistry, 298(11), p. 102570.

Tang, H. et al. (2023) “Ebola virus–like particles reprogram cellular metabolism,” Journal of Molecular Medicine [Preprint]. 

Vatzia, E. et al. (2021). Respiratory and intramuscular immunization with ChAdOx2 NPM1-NA induces distinct immune responses in H1N1pdm09 pre-exposed pigs. Research Square (preprint).

Mahari, S. et al. (2020). eCovSens-Ultrasensitive Novel In-House Built Printed Circuit Board Based Electrochemical Device for Rapid Detection of nCovid-19 antigen, a spike protein domain 1 of SARS-CoV-2. BioRxiv. Apr 29. (Preprint).

Pedraza-Escalon, M. et al. (2020). Isolation and characterization of high anity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. Research Square (preprint).

Roberts, A. et al. (2020). Graphene functionalized field-effect transistors for ultrasensitive detection of Japanese encephalitis and Avian influenza virus. Sci Rep. Sep 3;10(1). PMID: 32884083

Tuekprakhon, A. et al. (2018). Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development. PLoS One. PMID: 30557365

Kennedy, EM. et al. (2019). A Vaccine Based on Recombinant Modified Vaccinia Ankara Containing the Nucleoprotein From Lassa Virus Protects Against Disease Progression in a Guinea Pig Model. Vaccine, 37(36), 5404-5413. PMID: 31331770

Akpogheneta, O. et al. (2021). Boosting understanding of Lassa Fever virus epidemiology: Field testing a novel assay to identify past Lassa Fever virus infection in blood and oral fluids of survivors and unexposed controls in Sierra Leone. PLoS Neg. Tr. Dis.

Doremalen, NV. et al. (2021). ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys. BioRxiv (preprint).

Malcom, THT. et al (2021). Fucoidan But Not 2′-Fucosyllactose Inhibits Human Norovirus Replication in Zebrafish Larvae. Viruses 2021, 13(3), 461.

Ertsgaard, C.T. et al. (2022) “Open-channel microfluidics via Resonant Wireless Power Transfer,” Nature Communications, 13(1). 

Alzahrani, A. et al. (2023) “Non-spherical gold nanoparticles enhanced fluorescence of carbon dots for norovirus-like particles detection,” Journal of Biological Engineering, 17(1). 

Artman, C. et al. (2022) “Feasibility of polyclonal avian immunoglobulins (igy) as prophylaxis against human norovirus infection,” Viruses, 14(11), p. 2371.

Shaw, AM. et al. (2020). Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting with COVID-19 syndrome. Analyst. 2020 July 07: 5638-5646.

Pedraza-Escalon, M. et al. (2020). Isolation and characterization of high anity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. Research Square (preprint).

Tuekprakhon, A. et al. (2018). Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development. PLoS One. PMID: 30557365

Afsahi, S. et al. (2018). Novel graphene-based biosensor for early detection of Zika virus infection. Biosens Bioelectron. 100:85-88. PMID: 28865242

Balmaseda, A. et al. (2017). Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A. Aug 1;114(31):8384-8389. PMID: 28716913

Balmaseda, A. et al. (2018). Comparison of four serological methods and two RT-PCR assays for diagnosis and surveillance of Zika. J Clin Microbiol. Jan 5. pii: JCM.01785-17. doi: 10.1128/JCM.01785-17. [Epub ahead of print]. PMID: 29305550

Bedin, F. et al. (2017). Paper-based point-of-care testing for cost-effective diagnosis of acute flavivirus infections. J Med Virol. Sep;89(9):1520-1527. PMID: 28295400

Bhardwaj, U. and Singh, SK. (2021). Zika Virus NS1 Suppresses VE-Cadherin and Claudin-5 via hsa-miR-101-3p in Human Brain Microvascular Endothelial Cells. Mol Neurobiol. 2021 Sep 6. PMID: 34487317.

Bosch, I. et al. (2017). Rapid Antigen Tests for Dengue Virus Serotypes and Zika Virus In Patient Serum. Science Translational Medicine. PMID: 28954927

Cardenas, M and Noe, E. (2020). Optimization of Recombinant Flavivirus Antigens for Infection Serology: Towards Syndrome-Based Multiplex Tests. The Open University. Mar 03. (PhD thesis).

Chao, C-H. et al. (2019). Dengue Virus Nonstructural Protein 1 Activate Platelets via Toll-Like Receptor 4, Leading to Thrombocytopenia and Hemorrhage. PLOS Pathogens. PMID: 31009511

Conde, JN. et al. (2016). Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins. J Virol. Oct 14;90(21):9570-9581. PMID: 27512066

Delfin-Riela, T. et al. (2023) “Nanobody-based blocking of binding Elisa for the detection of anti-NS1 zika-virus-specific antibodies in convalescent patients,” Tropical Medicine and Infectious Disease, 8(1), p. 55.

de Puig, H. et al. (2022) “Multiplexed rapid antigen tests developed using multicolored nanoparticles and cross-reactive antibody pairs: Implications for pandemic preparedness,” Nano Today, 47, p. 101669.

Ganganboina, AB. et al. (2021). Cargo encapsulated hepatitis E virus-like particles for anti-HEV antibody detection. Biosens Bioelectron. 2021 Aug 1;185:113261. PMID: 33962156

Henry, P-G. et al. (2020). Zika Virus Nonstructural Protein 1 Disrupts Glycosaminoglycans and Causes Permeability in Developing Human Placentas. J Infect Dis. Jan, 221(2), 313-324. PMID: 31250000

Kareinen, L. et al. (2019). Immunoassay for serodiagnosis of Zika virus infection based on time-resolved Förster resonance energy transfer. PLoS One. Jul, 14(7). PMID: 31335898

Katzelnick, LC. et al. Zika virus infection enhances future risk of severe dengue disease. Science. Aug, 369(6507):1123-1128. PMID: 32855339

Lecouturier, V. et al. (2019). Immunogenicity and Protection Conferred by an Optimized Purified Inactivated Zika Vaccine in Mice. Vaccine. May, 37(2), 2679-2686. PMID: 30967310

Lecouturier, V. et al. (2020). An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques. NPJ Vaccines. Mar 12;5:19. PMID: 32194996

Limonta, D. et al. (2018). Human Fetal Astrocytes Infected with Zika Virus Exhibit Delayed Apoptosis and Resistance Interferon: Implications for Persistance. Viruses. PMID: 30453621

Margulis, M. et al. (2021). Optical modulation biosensing system for rapid detection of biological targets at low concentrations. Biomedical Optics Express. Vol. 12, Issue 9, pp. 5338-5350 (2021).

Matsanuga, K-I. et al. (2021). High-affinity five/six-letter DNA aptamers with superior specificity enabling the detection of dengue NS1 protein variants beyond the serotype identification. Nucleic Acids Res. 2021 Jun 25;gkab515. PMID: 34169309

Merbah, M. et al. (2020). A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins. J Immunol Methods. 2020 Oct 3;112874. PMID: 33022219.

Michelson, Y. et al. (2019). Highly Sensitive and Specific Zika Virus Serological Assays Using a Magnetic Modulation Biosensing System. J Infect Dis. Mar, 219(7), 1035-1043. PMID: 30335151

Nascimento, EJM. et al. (2018). Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus. J Virol Methods. Mar 19;257:48-57. PMID: 2956751

Nascimento, EJM. et al. (2019). Use of a Blockade-of-Binding ELISA and Microneutralization Assay to Evaluate Zika Virus Serostatus in Dengue-Endemic Areas. Am J Trop Med Hyd. Sep 101(3);708-715. PMC6726926

Park, C. et al. (2020). A Simple Method for the Design and Development of Flavivirus NS1 Recombinant Proteins Using an In Silico Approach. Biomed Res Int. Feb 13;2020:3865707. PMID: 32104691

Puerta-Guardo, H. et al. (2019). Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism. Cell Reports. PMID: 30726741

Puerta-Guardo, et al. (2020). Zika Virus Nonstructural Protein 1 Disrupts Glycosaminoglycans and Causes Permeability in Developing Human Placentas. J Infect Dis. Jan 2;221(2):313-324. PMID: 31250000

Rodriguez-Barraquer, et al. (2019). Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. Feb 363(6427);607-610. PMID: 30733412

Sanchez-Vargas, et al. (2021). Non-structural protein 1-specific antibodies directed against Zika Virus in humans mediate antibody-dependent cellular cytotoxicity. Immunology. PMID: 34056709

Shriver-Lake, LC. et al. (2018). Selection and Characterization of Anti-Dengue NS1 Single Domain Antibodies. Scientific Reports. PMID: 30591706

Shukla, A. et al. (2021). Zika virus NS1 suppresses the innate immune responses via miR-146a in human microglial cells. Int J Biol Macromol. 2021 Nov 16;S0141-8130(21)02459-4. PMID: 34798192

Theillet, G. et al. (2018). Laser-cut paper-based device for the detection of dengue non-structural NS1 protein and specific IgM in human samples. Arch Virol. Mar 10. doi: 10.1007/s00705-018-3776-z. [Epub ahead of print] PMID: 29525973

Ushijima, Y. et al. (2021). Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis. 2021 Mar 17;21(1):265. PMID: 33731022.

Whitehead and Pierson (2019). Effects of Dengue Immunity on Zika Virus Infection. Nature News and Views. Nature 567, 467-468 (2019).

Yeung, J. (2020). Zika Virus Infection Modulates Expression of Regulatory Complement Factors in SH-SY5Y Cells. (Master’s Thesis).

Zhang, B. et al. (2017). Diagnosis of Zika virus infection on a nanotechnology platform. Nat Med. May;23(5):548-550. PMID: 28263312

Martinez-Sobrido, L. and Toral, FA. (2019). New Advances on Zika Virus Research. Viruses. PMID: 30875715

Nasrin, F. et al. (2021). Design and Analysis of a Single System of Impedimetric Biosensors for the Detection of Mosquito-Borne Viruses. Biosensors (Basel). 2021 Oct 7;11(10):376. PMID: 34677332

Rayner, JO. et al. (2018). Comparative Pathogenesis of Asian and African-Lineage Zika Virus in Indian Rhesus Macaque’s and Development of Non-Human Primate Model Suitable for the Evaluation of New Drugs and Vaccines. Viruses. PMID: 29723973

Seiler, BT. (2019). Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment. F1000 Research. PMID: 31275563.

Awadalkareem, A. et al. (2021). A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission. NPJ Vaccines. 2021 Feb 17;6(1):27. PMID: 33597526.

Awadalkareem, A. et al. (2018). Multiplexed FluroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells. The Journal of Immunology. PMID: 30413671

Collins, MH. et al. (2019). Human Antibody Response to Zika Targets Type-Specific Quaternary Structure Epitopes. JCI Insight. PMID: 30996133

Lima, TM. et al. (2019). Purification of Flavivirus VLPs by a Two-Step Chomatographic Process. Vaccine. Nov, 37(47), 7061-7069. PMID: 31201056

Ponndorf, D. et al. (2020). Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice. Plant Biotechnology Journal. PMID: 33099859

Sanchez-Vargas, et al. (2021). Non-structural protein 1-specific antibodies directed against Zika Virus in humans mediate antibody-dependent cellular cytotoxicity. Immunology. PMID: 34056709

Tsuji, I. et al. (2022) “Somatic hypermutation and framework mutations of variable region contribute to Anti-Zika virus-specific monoclonal antibody binding and function,” Journal of Virology, 96(11).

Valenzuela-Leon, PC. et al. (2022). Multiple Salivary Proteins from Aedes aegypti Mosquito Bind to the Zika Virus Envelope Protein. Viruses 2022, 14(2), 221.

Ganganboina, AK. et al. (2021). Cargo encapsulated Hepatitis E virus-like particles for anti-HEV antibody detection. Biosensors and Bioelectronics. 2021 Apr.

Langerak, T. et al. (2022) “Comparative analysis of in vitro models to study antibody-dependent enhancement of zika virus infection,” Viruses, 14(12), p. 2776. 

Langerak, T. et al. (2022) “Transplacental Zika virus transmission in ex vivo perfused human placentas,” PLOS Neglected Tropical Diseases, 16(4). 

Michelson, Y. et al. (2019). Highly Sensitive and Specific Zika Virus Serological Assays Using a Magnetic Modulation Biosensing System. J Infect Dis. Mar, 219(7), 1035-1043. PMID: 30335151

Mumtaz, N. et al. (2022) “Zika virus alters osteogenic lineage progression of human mesenchymal stromal cells,” Journal of Cellular Physiology, 238(2), pp. 379–392.

Mumtaz, N. et al. (2022) “Zika virus infects human osteoclasts and blocks differentiation and bone resorption,” Emerging Microbes & Infections, 11(1), pp. 1621–1634.

Nasrin, F. et al. (2021). Design and Analysis of a Single System of Impedimetric Biosensors for the Detection of Mosquito-Borne Viruses. Biosensors, 11(10), 376. MDPI.

Pedraza-Escalon, M. et al. (2020). Isolation and characterization of high anity and highly stable anti-Chikungunya virus antibodies using ALTHEA Gold Libraries™. Research Square (preprint).

Ponndorf, D. et al. (2020). Plant‐made dengue virus‐like particles produced by co‐expression of structural and non‐structural proteins induce a humoral immune response in mice. Plant Biotechnology Journal. PMID: 33099859

Tuekprakhon, A. et al. (2018). Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development. PLoS One. PMID: 30557365

Ward, D. et al. (2022) “Sero-Epidemiological Study of Arbovirus Infection Following the 2015–2016 zika virus outbreak in Cabo Verde,” Scientific Reports, 12(1). 

Kim, YC. et al. (2021). Development of Zika NS1 ELISA methodology for seroprevalence detection in a cohort of Mexican patients in an endemic region. Journal of Clinical Virology Plus. 1(3).